Identity
- Security key
- 14532
- Ticker
- DYN
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2020-09-17
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- DYN
Detail
Enriched 2026-08-14 20:47
- Market cap
- $4,887,154,099.27
- Shares outstanding (class)
- 186,746,431
- Shares outstanding (weighted)
- 186,746,431
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 258
- Location
- WALTHAM, MA
- Homepage
- https://www.dyne-tx.com
- Description
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
Market cap and share counts drift.